Mutagenic impurities in pharmaceuticals: A critique of the derivation of the cancer TTC (Threshold of Toxicological Concern) and recommendations for structural-class-based limits-Reference-Cited by-同舟云学术

Mutagenic impurities in pharmaceuticals: A critique of the derivation of the cancer TTC (Threshold of Toxicological Concern) and recommendations for structural-class-based limits

Published:2013-11 Issue:2 Volume:67 Page:299-316
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Snodin David J.,McCrossen Sean D.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference101 articles.

1. Allyl chloride, CPDB, (last accessed 23.07.13).

2. Amberg, A., et al., 2006. Influence of solvents on Ames II results of different carboxylic acid halides. The Toxicologist 90, Abstract 522. (last accessed 14.05.13).

3. Paracelsus to parascience: the environmental cancer distraction;Ames;Mutat. Res.,2000

4. APVMA, 2010. Evaluation of S-abscisic acid. (last accessed 14.05.13).

5. Prediction of rodent carcinogenicity of 30 chemicals;Ashby;Environ. Health Perspect.,1996

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines;Regulatory Toxicology and Pharmacology;2023-06

2. Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance;Regulatory Toxicology and Pharmacology;2022-06

3. Evolution of Quantitative Structure–Activity Relationships ((Q)SAR) for Mutagenicity;Mutagenic Impurities;2021-12-08

4. ICH M7 – Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk;Mutagenic Impurities;2021-12-08

5. Historical Perspective on the Development of the EMEA Guideline and Subsequent ICH M7 Guideline;Mutagenic Impurities;2021-12-08